Agency Links:    Home   Contact Us    Compliments & Complaints   Help    Site Map
Link to Homepage

Patient/Public Info  |  Regional Services  |  Health Professionals Info  |  About BCCA  |  Research  |  Donating

Sarcoma

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use available at www.bccancer.bc.ca/legal.htm . 


 
PLEASE NOTE: All links in the table below open PDF documents .

AVAILABLE DOCUMENTS
(revision date indicated in red)
SAAI: Therapy for advanced soft tissue sarcoma using Doxorubicin, Ifosfamide-Mesna. Protocol (01 Feb 2010) 
SAAJA: Doxorubicin for Adjuvant Use for Patients with Non-Metastatic Operable Large High Grade Soft Tissue Sarcoma.  - Protocol (01 May 2009)
 - Preprinted order (27 Jun 2011)
SAAJADIC: Therapy for soft tissue sarcoma using Doxorubicin and Dacarbazine (DTIC). -  Protocol (01 Jun 2010)
 Preprinted order (29 Jun 2011)
SAAVA: Therapy for advanced soft tissue sarcoma using Doxorubicin.  - Protocol (01 May 2009)
 -  Preprinted order (27 Jun 2011)
SAAVGEMD: Second or Third Line Therapy for Soft Tissue Sarcomas using Gemcitabine and Docetaxel -  Protocol (01 Sep 2011)
 Preprinted order (27 Jun 2011)
SAAVI: Therapy for advanced soft tissue sarcoma using Ifosfamide.  - Protocol (01 Feb 2010)
 - See regional centre's inpatient order 
SAAVADIC: Therapy for advanced soft tissue sarcoma using Doxorubicin and Dacarbazine (DTIC) Protocol (01 Jun 2010)
 Preprinted order (29 Jun 2011)
SADTIC: High Dose Single Agent Dacarbazine (DTIC) for Metastatic Soft Tissue Sarcoma  - Protocol (01 Jun 2010)
 - Preprinted order (29 Jun 2011) 
SAVDCM: Adjuvant Therapy for Rhabdomyosarcoma using Vincristine, Dactinomycin, Cyclophosphamide and Mesna Protocol (01 Jan 2010)
SAAJGI: Adjuvant Treatment of C-Kit Positive High Risk Gastrointestinal Stromal Cell Tumours Using Imatinib  - Protocol (01 Jan 2012)
 - Preprinted order (1 Nov 2011)
 - Patient handout (01 Oct 2009)
SAAVGI: Treatment of Advanced c-Kit positive and c-Kit Negative Gastrointestinal Stromal Cell Tumors (GIST's) Using Imatinib Protocol (1 Nov 2011)
Preprinted order (1 Nov 2011)
SAAVGIDD: Treatment of advanced c-kit positive gastrointestinal stromal cell tumors (GIST's) using 800mg Dosing of imatinib Protocol (01 Jun 2011)
Preprinted order (1 Nov 2011)
SAAVGS: Second Line Treatment of Advanced C-kit Positive Gastrointestinal Stromal Cell Tumours (GIST's) After Imatinib Using Sunitinib (SUTENT®) Protocol (1 Nov 2011)
 - Preprinted order (1 Nov 2011)
 - Patient handout (1 Nov 2011)
SAAJAP: Adjuvant Therapy for Osteosarcoma Using Doxorubicin and Cisplatin. Protocol (01 Oct 2009)
 - See regional centre's inpatient order (O4 Apr 2005)
SAAVAP: Therapy of Advanced Osteosarcoma Using Doxorubicin and Cisplatin Protocol (01 Oct 2009)
 - See regional centre's inpatient order (O4 Apr 2005)
SAHDMTX: Treatment of Osteosarcoma Using High Dose Methotrexate with Leucovorin Rescue Protocol (01 May 2009)

SAMV: Palliative Therapy for Aggressive Fibromatosis Using Weekly or Alternate Week Methotrexate and Vinblastine Intravenously  Protocol (01 May 2009)
 - Preprinted order (01 May 2009)
SATAM: Therapy for recurrent desmoid tumors/aggressive fibromatosis using Tamoxifen
 - Protocol (01 May 2009)
 -  Preprinted order (O1 May 2009)
SAIME: Etoposide, ifosfamide-mesna for patients with newly diagnosed Ewing's sarcoma/peripheral neuroectodermal tumor (PNET) or rhabdomyosarcoma or advanced soft tissue or bony sarcomas  - Protocol (01 Feb 2010)
 - Preprinted order (27 Jun 2011)

SAVAC: Adjuvant therapy for newly diagnosed Ewing's sarcoma/peripheral neuroectodermal tumor (PNET) or rhabdomyosarcoma using Vincristine, Doxorubicin and Cyclophosphamide (this is alternated with SAIME)  Protocol (05 Jul 2011)
 -  Preprinted order (05 Jul 2011)

SAVACM: Therapy for newly diagnosed Ewing's sarcoma/peripheral neuroectodermal tumor (PNET) and rhabdomyosarcoma with pelvic primaries or chemotherapy induced hematuria using Vincristine, Doxorubicin and Cyclophosphamide. (SAVACM is alternated with SAIME)  - Protocol (01 Feb 2010)